Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Relapsed or Refractory Multiple Myeloma
about
Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Relapsed or Refractory Multiple Myeloma
description
clinical trial
@en
klinisch onderzoek
@nl
name
Trametinib and Akt Inhibitor G ...... or Refractory Multiple Myeloma
@en
type
label
Trametinib and Akt Inhibitor G ...... or Refractory Multiple Myeloma
@en
prefLabel
Trametinib and Akt Inhibitor G ...... or Refractory Multiple Myeloma
@en
P1050
P1476
A Phase 2 Study of Sequential ...... or Refractory Multiple Myeloma
@en
P17
P3098
NCT01989598
P4844
P580
2013-10-30T00:00:00Z
P582
2018-12-31T00:00:00Z